NEXGEL Reschedules Fourth Quarter and Full Year 2023 Financial Results Conference Call to Monday, April 1st at 8:30 a.m. ET Due to Holiday
March 27, 2024 09:00 ET
|
NEXGEL, INC.
LANGHORNE, Pa., March 27, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including...
AgeX Therapeutics Reports Fourth Quarter and Annual 2023 Financial Results
March 22, 2024 17:27 ET
|
AgeX Therapeutics, Inc.
ALAMEDA, Calif., March 22, 2024 (GLOBE NEWSWIRE) -- AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, reported...
NEXGEL to Report Fourth Quarter and Full Year 2023 Financial Results on March 28th
March 21, 2024 09:00 ET
|
NEXGEL, INC.
Management will host a conference call at 4:30 P.M. ET on the same day LANGHORNE, Pa., March 21, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading...
MEGA MATRIX CORP. Provides Business Update
March 18, 2024 16:15 ET
|
Mega Matrix Corp
Mega Matrix Corp. ("MPU" or the "Company") (NYSE American: MPU), today announced financial results for its fiscal year ended December 31, 2023.
Sacks Parente Golf, Inc. Announces Year End 2023 Financial Results and Provides Corporate Update
March 18, 2024 08:00 ET
|
Sacks Parente Golf, Inc.
Camarillo, Calif., March 18, 2024 (GLOBE NEWSWIRE) -- Sacks Parente Golf, Inc. (NASDAQ:SPGC), (the “Company” or “Sacks Parente”), a technology-forward golf company with a growing portfolio of golf...
Healthcare Triangle, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
March 15, 2024 09:28 ET
|
Healthcare Triangle, Inc
PLEASANTON, Calif., March 15, 2024 (GLOBE NEWSWIRE) -- Healthcare Triangle, Inc. (Nasdaq: HCTI) (“Healthcare Triangle,” “HCTI” or the “Company”), a leader in digital transformation solutions...
MaxCyte Reports Fourth Quarter and Full Year 2023 Financial Results and Reiterates 2024 Guidance
March 12, 2024 16:05 ET
|
MaxCyte, Inc.
MaxCyte Reports Fourth Quarter and Full Year 2023 Financial Results and Reiterates 2024 Guidance ROCKVILLE, MD, March 12, 2024 — MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering...
Mithra reports full year 2023 financial results
March 08, 2024 01:00 ET
|
Mithra Pharmaceuticals
Mithra reports full year 2023 financial results Revenues were EUR 40.2 million, down from the 2022 result of EUR 67.0 million which was positively impacted by exceptional upfront cash payments from...
RESEARCH FRONTIERS TO HOST YEAR-END 2023 CONFERENCE CALL
March 04, 2024 08:30 ET
|
Research Frontiers Incorporated
WOODBURY, NY, March 04, 2024 (GLOBE NEWSWIRE) -- Research Frontiers Inc. (Nasdaq: REFR) announced today that it will release its fourth quarter and full-year 2023 financial results on Thursday,...
Cox Energy, Coxabengoa’s Energy Division, Tripled Its Revenues During 2023 to 1,279 Million Mexican Pesos, With an EBITDA of More Than 350 Million Mexican Pesos
February 29, 2024 18:28 ET
|
Cox Energy
Cox Energy, part of Coxabengoa, tripled its revenue to MXN 1.279 billion in 2023, with an EBITDA of over MXN 350 million, expanding its energy projects.